Over-expression of hypoxia-inducible factor-1α increases the invasive potency of LNCaP cells in vitro

BJU International

Volumn 98, Issue 6, 2006, Pages 1315-1319

  Luo, Yong ^a,b   He, Da Lin ^a,b   Ning, Liang ^a,b   Shen, Shu Lin ^a,b   Li, Lei ^a,b   Li, Xiang ^a,b   Zhau, Haiyen E ^c   Chung, Leland W K ^c  

^a THE FIRST AFFILIATED HOSPITAL OF XI AN JIAOTONG UNIVERSITY   (China)

^b XI'AN JIAOTONG UNIVERSITY   (China)

^c EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

HIF 1 ; Invasive potency; Prostate cancer

Indexed keywords

CATHEPSIN D; GELATINASE A; HYPOXIA INDUCIBLE FACTOR 1ALPHA; UROKINASE RECEPTOR; UVOMORULIN; VIMENTIN;

ARTICLE; CANCER INVASION; CONTROLLED STUDY; DOWN REGULATION; GENE EXPRESSION REGULATION; GENE OVEREXPRESSION; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; IMMUNOFLUORESCENCE; MALE; MOLECULAR CLONING; PRIORITY JOURNAL; PROSTATE CANCER; UPREGULATION; WESTERN BLOTTING;

BLOTTING, WESTERN; HUMANS; HYPOXIA-INDUCIBLE FACTOR 1, ALPHA SUBUNIT; MALE; NEOPLASM INVASIVENESS; PROSTATIC NEOPLASMS; TRANSFECTION; TUMOR CELLS, CULTURED;

EID: 33750846905     PISSN: 14644096     EISSN: 1464410X     Source Type: Journal    
DOI: 10.1111/j.1464-410X.2006.06480.x     Document Type: Article

References (28)

1. Harris AL. Hypoxia - a key regulatory factor in tumor growth. Nat Rev Cancer 2002; 2: 38-47
2. Semenza GL. Targeting HIF-1 for cancer therapy. Nat Rev Cancer 2003; 3: 721-32
3. Zagzag D, Zhong H, Scalzitti JM, Laughner E, Simons JW, Semenza GL. Expression of hypoxia-inducible factor 1α in brain tumors: association with angiogenesis, invasion, and progression. Cancer 2000; 88: 2606-18
4. Zhong H, De Marzo AM, Laughner E et al. Overexpression of hypoxia-inducible factor 1α in common human cancers and their metastases. Cancer Res 1999; 59: 5830-5
5. Thalmann GN, Sikes RA, Wu TT et al. LNCaP progression model of human prostate cancer: androgen-independence and osseous metastasis. Prostate 2000; 44: 91-103
6. Liotta LA. Tumor invasion and metastases - role of the extracellular matrix: Rhodes Memorial Award Lecture. Cancer Res 1986; 46: 1-7
7. Semaan M, Jovenin N, Birembaut P, Menard J, Staerman F. [Prognostic value of stromal immunolabelling by MMP-2, MT1-MMP and TIMP-2 in clinically localized prostate cancer]. Prog Urol 2005; 15: 250-4
8. Kobayashi H, Schmitt M, Goretzki L et al. Cathepsin B efficiently activates the soluble and the tumor cell receptor-bound form of the proenzyme urokinase-type plasminogen activator (Pro-uPA). J Biol Chem 1991; 266: 5147-52
9. Savagner P. Leaving the neighborhood: molecular mechanisms involved during epithelial mesenchymal transition. Bioessays 2001; 23: 912-23
10. Boyer B, Valles AM, Edme N. Induction and regulation of epithelial-mesenchymal transitions. Biochem Pharmacol 2000; 60: 1091-9
11. Barker N, Clevers H. Tumor environment: a potent driving force in colorectal cancer? Trends Mol Med 2001; 7: 535-7
12. Hendrix MJ, Seftor EA, Chu YW, Trevor KT, Seftor RE. Role of intermediate filaments in migration, invasion and metastasis. Cancer Metastasis Rev 1996; 15: 507-25
13. Turner KJ, Moore JW, Jones A et al. Expression of hypoxia-inducible factors in human renal cancer: relationship to angiogenesis and to the von Hippel-Lindau gene mutation. Cancer Res 2002; 62: 2957-61
14. Krieg M, Haas R, Brauch H, Acter T, Flamme I, Plate KH. Up-regulation of hypoxia-inducible factors HIF-1α and HIF-2α under normoxic conditions in renal carcinoma cells by von Hippel-Lindau tumor suppressor gene loss of function. Oncogene 2000; 19: 5435-43
15. Zhong H, Chiles K, Feldser D et al. Modulation of hypoxia-inducible factor 1α expression by the epidermal growth factor/phosphatidylinositol 3-kinase/PTEN/AKT/FRAP pathway in human prostate cancer cells: implications for tumor angiogenesis and therapeutics. Cancer Res 2000; 60: 1541-5
16. Zundel W, Schindler C, Haas-Kogan D et al. Loss of PTEN facilitates HIF-1-mediated gene expression. Genes Dev 2000; 14: 391-6
17. Laughner E, Taghavi P, Chiles K, Mahon PC, Semenza GL. HER2 (neu) signaling increases the rate of hypoxia-inducible factor 1α (HIF-1α) synthesis: novel mechanism for HIF-1-mediated vascular endothelial growth factor expression. Mol Cell Biol 2001; 21: 3995-4004
18. Fukuda R, Kelly B, Semenza GL. Vascular endothelial growth factor gene expression in colon cancer cells exposed to prostaglandin E2 is mediated by hypoxia-inducible factor 1. Cancer Res 2003; 63: 2330-4
19. Kondo Y, Hamada J, Kobayashi C et al. Over expression of hypoxia-inducible factor-1α in renal and bladder cancer cells increases tumorigenic potency. J Urol 2005; 173: 1762-6
20. Wang Y, Pakunlu RI, Tsao W, Pozharov V, Minko T. Bimodal effect of hypoxia in cancer: role of hypoxia inducible factor in apoptosis. Mol Pharm 2004; 1: 156-65
21. Yu L, Liu Y, Cui Y. Expression of hypoxia inducible factor-1α and its relationship to apoptosis and proliferation in human laryngeal squamous cell carcinoma. J Huazhong Univ Sci Technolog Med Sci 2004; 24: 636-8
22. Liu XH, Yu EZ, Li YY, Kagan E. HIF-1α has an anti-apoptotic effect in human airway epithelium that is mediated via Mcl-1 gene expression. J Cell Biochem 2006; 97: 755-65
23. Akakura N, Kobayashi M, Horiuchi I et al. Constitutive expression of hypoxia-inducible factor-1α renders pancreatic cancer cells resistant to apoptosis induced by hypoxia and nutrient deprivation. Cancer Res 2001; 61: 6548-54
24. Bos R, van Diest PJ, van der Groep P, Shvarts A, Greijer AE, van der Wall E. Expression of hypoxia-inducible factor-1α and cell cycle proteins in invasive breast cancer are estrogen receptor related. Breast Cancer Res 2004; 6: R450-9
25. Bos R, van Diest PJ, de Jong JS, van der Groep P, van der Valk P, van der Wall E. Hypoxia-inducible factor-1α is associated with angiogenesis, and expression of bFGF, PDGF-BB, and EGFR in invasive breast cancer. Histopathology 2005; 46: 31-6
26. Price JT, Bonovich MT, Kohn EC. The biochemistry of cancer dissemination. Crit Rev Biochem Mol Biol 1997; 32: 175-253
27. Krishnamachary B, Berg-Dixon S, Kelly B et al. Regulation of colon carcinoma cell invasion by hypoxia-inducible factor 1. Cancer Res 2003; 63: 1138-43
28. Rapisarda A, Uranchimeg B, Scudiero DA et al. Identification of small molecule inhibitors of hypoxia-inducible factor 1 transcriptional activation pathway. Cancer Res 2002; 62: 4316-24